Cutia Therapeutics (HKSE:02487) Change In Inventory : HK$-35.2 Mil (TTM As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Cutia Therapeutics Change In Inventory?

Cutia Therapeutics's change in inventory for the quarter that ended in Dec. 2024 was HK$-12.4 Mil. It means Cutia Therapeutics's inventory increased by HK$12.4 Mil from Jun. 2024 to Dec. 2024 .

Cutia Therapeutics's change in inventory for the fiscal year that ended in Dec. 2024 was HK$-35.0 Mil. It means Cutia Therapeutics's inventory increased by HK$35.0 Mil from Dec. 2023 to Dec. 2024 .

Cutia Therapeutics's Total Inventories for the quarter that ended in Dec. 2024 was HK$79.7 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Cutia Therapeutics's Days Inventory for the quarter that ended in Dec. 2024 was 140.47.

Inventory Turnover measures how fast the company turns over its inventory within a year. Cutia Therapeutics's Inventory Turnover for the quarter that ended in Dec. 2024 was 1.30.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cutia Therapeutics's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.38.

Cutia Therapeutics Change In Inventory Historical Data

The historical data trend for Cutia Therapeutics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cutia Therapeutics Change In Inventory Chart

Cutia Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Change In Inventory

-2.21

-20.32

-27.69

-35.04

Cutia Therapeutics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Inventory	Get a 7-Day Free Trial			-8.95	-1.04	-26.66	-22.77	-12.45

Cutia Therapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-35.2 Mil.

Cutia Therapeutics (HKSE:02487) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cutia Therapeutics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	74.7115	/	97.064	*	365 / 2
	=	140.47

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cutia Therapeutics's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	97.064	/	74.7115
	=	1.30

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cutia Therapeutics's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	74.7115	/	196.494
	=	0.38

Cutia Therapeutics Change In Inventory Related Terms

Thank you for viewing the detailed overview of Cutia Therapeutics's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Cutia Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cutia Therapeutics (HKSE:02487) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

436 Heng Feng Road, 20th Floor, Huanzhi Building, Jingan District, Shanghai, CHN, 200070

Website

https://www.cutiatx.com

Cutia Therapeutics is a dermatology focused biopharmaceutical company focused on the broader dermatology treatment and care therapeutic areas, including localized adipose accumulation management medication, scalp diseases and care, skin diseases and care, and topical anesthesia. Its core product is CU-20401, which is a recombinant mutant collagenase that targets obesity, overweight, or other localized adipose accumulation-associated metabolic diseases. Its other products include CU-40102 (topical finasteride spray); CU-10201; CU-40101; and CU-10101 (topical novel small molecule agent) among others. Geographically, the company generates its revenue from the People's Republic of China.

Executives

Zhang Lele	2101 Beneficial owner
Zhang Qiping	2201 Interest of corporation controlled by you
Su Zhou Tong Yu Tou Zi Guan Li He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Su Zhou Tong He Yu Cheng Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
6 Dimensions Capital Gp, Llc	2201 Interest of corporation controlled by you
6 Dimensions Capital, L.p.	2101 Beneficial owner
Su Zhou Yun Zhang Tou Zi Zi Xun You Xian Gong Si	2201 Interest of corporation controlled by you
Yf Dermatology Limited	2101 Beneficial owner
Yunfeng Capital Limited	2102 Investment manager
Yunfeng Fund Iii, L.p.	2201 Interest of corporation controlled by you
Yunfeng Investment Iii, Ltd.	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Fil Limited	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Hsg Growth V Management, L.p.	2201 Interest of corporation controlled by you

Cutia Therapeutics Headlines

No Headlines